VERWENDUNG EINES ADAM9-INHIBITORS ALS IMMUNMODULATOR
European patent · EP3960171 · Deleted
Register entry
- Publication number
- EP3960171
- Application number
- EP20796014
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- Deleted
- Specification
- Granted
- Filed
- Apr 24, 2020
- Published
- Mar 2, 2022
- Granted
- Jan 1, 2025
- Deleted
- Nov 25, 2025
- Reason
- Annual fee unpaid
- IPC classes
- A61K 31/427 (2006.01)A61P 35/00 (2006.01)A61P 37/02 (2006.01)A61K 31/4439 (2006.01)A61K 31/454 (2006.01)A61K 31/4709 (2006.01)A61K 45/06 (2006.01)
- Priority
- US 201962839183 P 26.04.2019
- PCT application
- PCT/CN2020/086642 24.04.2020
- PCT publication
- WO2020/216319 29.10.2020
- Filing language
- Chinese
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Nov 25, 2025
Deleted, fee unpaid
- Status of protective title
- Active → Cancelled
- Cancellation date
- 25.11.2025
- Cause for cancellation
- Non-payment of renewal fee
Published in Swissreg on 25.11.2025
- Nov 12, 2025
Change
Published in Swissreg on 12.11.2025
- Jan 1, 2025
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 01.01.2025
Parties
Inventor
SHER, Yuh-pyng
Taichung City 404, Taiwan, TW
YANG, Juan-cheng
Tainan City 702, Taiwan, TW
LIU, Jing-pei
Yuanlin City, Changhua County, Taiwan, TW
HUANG, Yu-kai
Taipei City, Taiwan, TW
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.